{"schema_version":"1","generated_at":"2026-10-30T05:01:39.378Z","data_as_of":null,"url":"https://www.findmykol.com/kol/khema-sharma","json_url":"https://www.findmykol.com/kol/khema-sharma/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"khema-sharma","name":"Khema Sharma","specialty":"Neurology","specialty_raw":"Neurology","therapeutic_area":"Neurology","therapeutic_areas":["Neurology"],"institution":"University of Miami","institution_url":"https://www.findmykol.com/institution/university-of-miami","city":"Miami","state":"FL","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1801816095","openalex":"A5084462008"},"summary":"Khema Sharma is a Neurology physician affiliated with University of Miami. OpenAlex indexes 70 publications with 5,446 citations (h-index 36).","overview":null,"focus":{"indications":[],"research_topics":["Neurology"]},"scholarship":{"works_count":70,"cited_by_count":5446,"h_index":36,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":3,"program_years":{"first":2021,"last":null},"rows_total":5,"shown":3,"withheld":2,"rows":[{"payer":"ARGENX US, INC.","program_year":2025,"amount_usd":1477.18,"payment_count":9,"source_url":"https://openpaymentsdata.cms.gov/search?query=1801816095"},{"payer":"Janssen Research & Development, LLC","program_year":2025,"amount_usd":1254.18,"payment_count":7,"source_url":"https://openpaymentsdata.cms.gov/search?query=1801816095"},{"payer":"CSL Behring","program_year":2025,"amount_usd":352.98,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1801816095"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1801816095","source":"payments"},"prescribing":{"data_year":2024,"areas_total":4,"areas_shown":3,"areas":[{"area":"Nervous system","share_pct":66.2,"classes_total":5,"classes":[{"class":"Gabapentinoids","setting":"prescribed","share_pct":23.7,"drugs":[{"name":"Gabapentin","share_pct":87.8},{"name":"Pregabalin","share_pct":12.2}],"max_beneficiaries":null},{"class":"Cholinesterase Inhibitor","setting":"prescribed","share_pct":20,"drugs":[{"name":"Pyridostigmine Bromide","share_pct":68.7},{"name":"Pyridostigmine Bromide Er","share_pct":31.3}],"max_beneficiaries":null}]},{"area":"Metabolism & gastrointestinal","share_pct":24.6,"classes_total":2,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":18.1,"drugs":[{"name":"Prednisone","share_pct":100}],"max_beneficiaries":14},{"class":"Vitamin B12","setting":"prescribed","share_pct":6.5,"drugs":[{"name":"Cyanocobalamin Injection","share_pct":100}],"max_beneficiaries":null}]},{"area":"Cancer & immunology","share_pct":4.8,"classes_total":1,"classes":[{"class":"Purine Antimetabolite","setting":"prescribed","share_pct":4.8,"drugs":[{"name":"Azathioprine","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":82.7,"facility_pct":17.3},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study","year":2023,"journal":"The Lancet Neurology","source_url":"https://doi.org/10.1016/s1474-4422(23)00077-7","status":"verified"},{"title":"A Phase 1 study of <scp>GDC</scp>‐0134, a dual leucine zipper kinase inhibitor, in <scp>ALS</scp>","year":2022,"journal":"Annals of Clinical and Translational Neurology","source_url":"https://doi.org/10.1002/acn3.51491","status":"verified"},{"title":"Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension","year":2020,"journal":"Neurology","source_url":"https://doi.org/10.1212/wnl.0000000000011207","status":"verified"},{"title":"Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS)","year":2020,"journal":"JAMA Neurology","source_url":"https://doi.org/10.1001/jamaneurol.2020.2590","status":"verified"},{"title":"Eculizumab improves fatigue in refractory generalized myasthenia gravis","year":2019,"journal":"Quality of Life Research","source_url":"https://doi.org/10.1007/s11136-019-02148-2","status":"verified"}],"source":"works"},"contact":{"address_1":"1475 NW 12TH AVE","address_2":"BOX 016960 M851","city":"Miami","state":"FL","zip":"331361002","phone":"305-243-7520","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1801816095","source":"identity"},"similar":[{"name":"Carlos Singer","slug":"carlos-singer","institution":"University of Miami","specialty":"Neurology","url":"https://www.findmykol.com/kol/carlos-singer","json_url":"https://www.findmykol.com/kol/carlos-singer/profile.json"},{"name":"Sebastian Koch","slug":"sebastian-koch","institution":"University of Miami","specialty":"Neurology","url":"https://www.findmykol.com/kol/sebastian-koch","json_url":"https://www.findmykol.com/kol/sebastian-koch/profile.json"},{"name":"Jay Spiegel","slug":"jay-spiegel","institution":"University of Miami","specialty":"Hematology","url":"https://www.findmykol.com/kol/jay-spiegel","json_url":"https://www.findmykol.com/kol/jay-spiegel/profile.json"},{"name":"Kara Cavuoto","slug":"kara-cavuoto","institution":"University of Miami","specialty":"Ophthalmology","url":"https://www.findmykol.com/kol/kara-cavuoto","json_url":"https://www.findmykol.com/kol/kara-cavuoto/profile.json"},{"name":"Bruce Miller","slug":"bruce-miller","institution":"University of California, San Francisco (UCSF)","specialty":"Neurology","url":"https://www.findmykol.com/kol/bruce-miller","json_url":"https://www.findmykol.com/kol/bruce-miller/profile.json"},{"name":"Brett Kissela","slug":"brett-kissela","institution":"Medical College of Wisconsin","specialty":"Neurology","url":"https://www.findmykol.com/kol/brett-kissela","json_url":"https://www.findmykol.com/kol/brett-kissela/profile.json"},{"name":"Bradley Boeve","slug":"bradley-boeve","institution":"Mayo Clinic","specialty":"Neurology","url":"https://www.findmykol.com/kol/bradley-boeve","json_url":"https://www.findmykol.com/kol/bradley-boeve/profile.json"},{"name":"Richard Lipton","slug":"richard-lipton","institution":"Albert Einstein College of Medicine","specialty":"Neurology","url":"https://www.findmykol.com/kol/richard-lipton","json_url":"https://www.findmykol.com/kol/richard-lipton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":2,"publications":45}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2013-02-21","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}